Five-year disease-free survival (DFS) in African-American and Latina patients with either high or low pAkt together with their HER2/neu status

Kaplan-Meier survival curves were used to compare the 5-year DFS among patients with low pAkt/HER2(I, red), low pAkt/HER2(II, blue), high pAkt/HER2(III, fuchsia), and high pAkt/HER2(IV, green). The differences between the curves were estimated by log-rank test, and a value of less than 0.05 was considered statistically significant. *< 0.005, the indicated groups compared to group IV (high pAkt/HER2). ^= 0.03, between the indicated two groups.<p><b>Copyright information:</b></p><p>Taken from "Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer"</p><p>http://breast-cancer-research.com/content/10/1/R3</p><p>Breast Cancer Research : BCR 2008;10(1):R3-R3.</p><p>Published online 10 Jan 2008</p><p>PMCID:PMC2374954.</p><p></p

Five-year disease-free survival (DFS) in African-American and Latina women with breast cancer

Kaplan-Meier survival curves comparing 5-year DFS between African-American (green) and Latina (fuchsia) women. Kaplan-Meier survival curves comparing 5-year DFS in African-American and Latina women between less than 50 years of age (green) and above 50 years of age (fuchsia) at the time of diagnosis. The differences between the curves were estimated by log-rank test, and a value of less than 0.05 was considered statistically significant.<p><b>Copyright information:</b></p><p>Taken from "Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer"</p><p>http://breast-cancer-research.com/content/10/1/R3</p><p>Breast Cancer Research : BCR 2008;10(1):R3-R3.</p><p>Published online 10 Jan 2008</p><p>PMCID:PMC2374954.</p><p></p

Five-year disease-free survival (DFS) in African-American and Latina women with different levels of pAkt versus different types of breast cancer

Patients were grouped as low pAkt (median level of pAkt index of less than or equal to 36) and high pAkt (median level of pAkt index of greater than 36) . Then Kaplan-Meier survival curves were used to compare the 5-year DFS between patients with different subtypes of tumors: I, luminal A type of tumor (green); II, luminal B type of tumor (fuchsia); III, ER/PRand HER2tumor (blue); and IV, basal-like type of tumor (red). The differences between the curves were estimated by log-rank test, and a value of less than or equal to 0.05 was considered statistically significant. ER, estrogen receptor; N.S., no statistical significance between the curves; PR, progesterone receptor.<p><b>Copyright information:</b></p><p>Taken from "Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer"</p><p>http://breast-cancer-research.com/content/10/1/R3</p><p>Breast Cancer Research : BCR 2008;10(1):R3-R3.</p><p>Published online 10 Jan 2008</p><p>PMCID:PMC2374954.</p><p></p

Five-year disease-free survival (DFS) in African-American and Latina women with HER2/neu or pAkt status

Kaplan-Meier survival curves were used to compare the 5-year DFS between HER2/neu-positive (fuchsia) and HER2/neu-negative (green) tumors. A similar comparison between high pAkt (fuchsia) and low pAkt (green) tumors in African-American and Latina women. The differences between the curves were estimated by log-rank test, and a value of less than 0.05 was considered statistically significant.<p><b>Copyright information:</b></p><p>Taken from "Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer"</p><p>http://breast-cancer-research.com/content/10/1/R3</p><p>Breast Cancer Research : BCR 2008;10(1):R3-R3.</p><p>Published online 10 Jan 2008</p><p>PMCID:PMC2374954.</p><p></p

Five-year disease-free survival (DFS) in African-American and Latina women with ER/PRand HER2and basal-like (ER/PRHER2) subtypes of breast cancer versus different levels of pAkt

Kaplan-Meier survival curves were used to compare the 5-year DFS between patients with high pAkt (fuchsia) and low pAkt (green) and with ER/PRand HER2tumor and basal-like (ER/PR/HER2) tumor . The differences between the curves were estimated by log-rank test, and a value of less than or equal to 0.05 was considered statistically significant. ER, estrogen receptor; PR, progesterone receptor.<p><b>Copyright information:</b></p><p>Taken from "Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer"</p><p>http://breast-cancer-research.com/content/10/1/R3</p><p>Breast Cancer Research : BCR 2008;10(1):R3-R3.</p><p>Published online 10 Jan 2008</p><p>PMCID:PMC2374954.</p><p></p